Birmingham, West Midlands -- (SBWIRE) -- 12/18/2013 -- Value Penny Stocks issues special report on RF Micro Devices, Inc. (NASDAQ:RFMD), JDS Uniphase Corp (NASDAQ:JDSU), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Dendreon Corporation (NASDAQ:DNDN).
RF Micro Devices, Inc. (NASDAQ:RFMD) ended its recent business day with the gain of 0.10% and closed at the price of $5.04 after opening at $5.02. The stock traded during its last trading session with the total volume of 3,530,324 shares, as compared to its average volume of 3.33 million shares. RF Micro Devices, Inc. engages in the design, development, manufacture, and marketing of radio frequency (RF) solutions for original equipment manufacturers and original design manufacturers in wireless and wired communications applications in the United States and internationally.
For How Long RFMD will Fight for Profitability? Read This Trend Analysis report
JDS Uniphase Corp (NASDAQ:JDSU) remained among the day advancers and traded with volume of 3,510,777 shares in the last session, as compared to average volume of 4.29 million shares. In comparison with 52 week range of $11.70 - $16.61, it faced lowest price of $12.08 during the last trading session whereas its day highest price was $12.37. The company’s total market capitalization is $2.87 billion, along with 232.84 million shares outstanding. JDS Uniphase Corporation provides communications test and measurement solutions, and optical products for telecommunications service providers, wireless operators, cable operators, network-equipment manufacturers, original equipment manufacturers, enterprises, government organizations, distributors, and strategic partners worldwide.
For How Long JDSU’s Gloss will Attract Investors? Find out via this report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) showed 3,424,024 shares in volume during the last trading session, while the average trading volume remained 2.46 million shares. The stock kicked off its trading session at $2.82 and closed at $2.68 after declining -4.96%. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Why Should Investors Buy AVNR After the Recent Fall? Just Go Here and Find Out
Dendreon Corporation (NASDAQ:DNDN) stock traded during its last trading session with the total traded volume of 3,362,488 shares versus its average volume of 3.49 million shares. The company opened its trade at the price of $3.29 and its closing price was $3.28 after losing -0.91% for the day. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Will DNDN Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)